MoonLake Immunotherapeutics
MLTX
£29.78
Share price
0.31%
Change (1 day)
-21.92%
Change (1 year)
Categories
Revenue for MoonLake Immunotherapeutics (MLTX)
Revenue in 2024 (TTM): N/A
a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for MoonLake Immunotherapeutics from 2022 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
2024  | N/A | |
| 2023 | N/A | |
| 2022 | N/A |